Join the biggest pharma event in Spain,
where innovation takes centre stage!
Meet team IOLCP at
24th - 26th October 2023
Fira Barcelona Gran Via, Spain
Stand No #6B60, Hall No 6
About CPHI Barcelona 2023
CPHI is one of the largest international pharma events where leading pharma companies from all over the world meet in person and network together.
With CPHI Barcelona, you can take your pharma business to the next level. This event aims to provide endless opportunities for networking, including the chance to participate in events and engage with other professionals in your field.
Expand your knowledge and expertise by attending CPHI Barcelona, where you can learn from industry experts and stay up-to-date on the latest trends and innovations in pharma.
About IOLCP
We develop and manufacture APIs for major pharma companies around the world. Today, by leveraging our substantial production capabilities, we are now able to overcome cost and scale challenges.
APIs from our portfolio include Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant properties. We are the only backward-integrated firm producing all Intermediates and Key Starting Materials (KSMs) of ibuprofen.
IOLCP strives to achieve excellence at every stage of the value chain. Our unwavering commitment to excellence in operations, innovation, quality, and customer service has helped us become a market leader.
Learn moreWho we are
Founded 30 years ago, IOL Chemicals and Pharmaceuticals Limited is one of the most consistent pharma companies in delivering innovation-driven solutions to market needs.
30+
Years
50+
R&D experts
2000+
Workforce
Our Vison
To be amongst the most admired companies in APIs, Intermediaries, and Specialty Chemicals globally.
Know MoreOur Mission
To provide top quality products in APIs, Intermediates and Specialty Chemicals through continuous innovation and cutting-edge technology, with due regards to safety and environment.
Know MoreOur Values
We at IOL, believe values bring character to any organization that help leaders to guide teams for a culture of excellence through continuous improvements.
Know More
Our Portfolio
Our Milestones
-
1986
» 1986
IOL Chemicals and Pharmaceutical Limited was incorporated in 1986 with Acetic Acid Plant -
1996
» 1996
Commencement of Ethyl Acetate Plant -
1999
» 1999
Commencement of Acetic Anhydride Plant -
2000
» 2000
Commencement of Ibuprofen Unit-1 -
2007
» 2007
Established Unit-1 dedicated for Ibuprofen Established Multi fuel captive co-generation power plant of 4MW capacity -
2009
» 2009
Commencement of Iso Butyl Benezene, Mono Chloro Acetic Acid and Acetyl Chloride Plant leading to backward integration to Ibuprofen
-
2017
» 2017
Conversion of Unit-2 as dedicated facility for Ibuprofen -
2016
» 2016
Commencement of Unit-3 for new product launches -
2015
» 2015
USFDA EIR for Ibuprofen -
2013
» 2013
Received EUGMP certification -
2012
» 2012
Commencement of Unit-2 for Multi product -
2010
» 2010
IOL gets listed on the National Stock Exchange (NSE) Established Multi fuel captive co-generation power plant of 13MW capacity 2012
-
2018
» 2018
Established Unit-4 dedicated for Metformin Hydrochloride Unit-5 dedicated for Clopidogrel Bisulfate Form II & Fenofibrate -
2019
» 2019
Established Unit-6 dedicated for Pantoprazole Sodium -
2020
» 2020
Established Unit-7 dedicated for Metformin -
2021
» 2021
Established Unit-8 for Multi Products -
2022
» 2022
Began commercial production of Paracetamol -
2023
» 2023
Recommencement of Acetic Anhydride
Market Presence
